How the FDA is focused on improving clinical trial access, enrollment, and enhancing public trust and education

The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.

Related links

https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity

https://www.beaconpublichealth.com/